Summary of findings 2: Immunotherapies vs placebo
(4360) · adults with multiple sclerosis Interventions: immunosuppressive and immunomodulatory drugs Comparator: placebo Outcome: withdrawals due to…
2 findings from 1 review
- Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes onlyno estimate extracted7 studies · 2278 participantsLow
- Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis 2023 · Cochrane Headline outcomes onlyno estimate extracted7 studies · 2278 participantsVery low